Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood.
暂无分享,去创建一个
Zina M. Ibrahim | D. Geschwind | R. Dobson | S. Newhouse | A. Simmons | H. Soininen | P. Mecocci | B. Vellas | M. Tsolaki | I. Kloszewska | S. Lovestone | P. Proitsi | K. Lunnon | G. Coppola | A. Lourdusamy | A. Hodges | S. Furney | M. Sattlecker | Muzamil Saleem
[1] Angelyn R. Lao,et al. Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease , 2012, The EMBO journal.
[2] H. Soares,et al. Genome-wide association study identifies multiple novel loci associated with disease progression in subjects with mild cognitive impairment , 2011, Translational Psychiatry.
[3] Magda Tsolaki,et al. AddNeuroMed and ADNI: Similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America , 2011, NeuroImage.
[4] Eric M Reiman,et al. Functional Links Between Aβ Toxicity, Endocytic Trafficking, and Alzheimer’s Disease Risk Factors in Yeast , 2011, Science.
[5] S. Ghosh,et al. Mitochondria in innate immune responses , 2011, Nature Reviews Immunology.
[6] H. Erdjument-Bromage,et al. TLR signaling augments macrophage bactericidal activity through mitochondrial ROS , 2011, Nature.
[7] Zhinan Yin,et al. The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice , 2011, Science.
[8] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[9] Saskia B Wortmann,et al. Mutation in mitochondrial ribosomal protein MRPS22 leads to Cornelia de Lange-like phenotype, brain abnormalities and hypertrophic cardiomyopathy , 2011, European Journal of Human Genetics.
[10] B. Rossi,et al. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte–endothelial interactions , 2011, Journal of leukocyte biology.
[11] D. Perrais,et al. A High Precision Survey of the Molecular Dynamics of Mammalian Clathrin-Mediated Endocytosis , 2011, Microscopy and Microanalysis.
[12] D. Louis Collins,et al. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls , 2011, NeuroImage.
[13] J. Tschopp,et al. A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.
[14] Sandro Sorbi,et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. , 2011, Archives of neurology.
[15] Magda Tsolaki,et al. The AddNeuroMed framework for multi‐centre MRI assessment of Alzheimer's disease : experience from the first 24 months , 2011, International journal of geriatric psychiatry.
[16] Rui Luo,et al. Is My Network Module Preserved and Reproducible? , 2011, PLoS Comput. Biol..
[17] R. Mayeux,et al. Meta-analysis of plasma amyloid-β levels in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[18] Solve Sæbø,et al. A gene expression pattern in blood for the early detection of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[19] R. Nitrini,et al. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[20] James Sayre,et al. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids. , 2011, Journal of Alzheimer's disease : JAD.
[21] Sean D Sullivan,et al. Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[22] D. Aarsland,et al. A novel blood test for the early detection of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[23] D. Butterfield,et al. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder. , 2011, Journal of Alzheimer's disease : JAD.
[24] Brenda L. Lyon,et al. A Conceptual Overview , 2011 .
[25] K. Lunetta,et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. , 2010, Archives of neurology.
[26] Grace Y Chen,et al. Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.
[27] N. Herrmann,et al. A Meta-Analysis of Cytokines in Alzheimer's Disease , 2010, Biological Psychiatry.
[28] P. Kubes,et al. Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation , 2010, Science.
[29] C. D. de Jager,et al. Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post‐mortem diagnosis , 2010, International journal of geriatric psychiatry.
[30] Guanghua Xiao,et al. A serum protein-based algorithm for the detection of Alzheimer disease. , 2010, Archives of neurology.
[31] K. Szekeres,et al. Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic Mice , 2010, The Journal of Neuroscience.
[32] Seth Love,et al. Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease , 2010, PloS one.
[33] George Perry,et al. Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. , 2010, International journal of clinical and experimental pathology.
[34] S. Horvath,et al. Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways , 2010, Proceedings of the National Academy of Sciences.
[35] B. Winblad,et al. Rethinking Alzheimer's disease therapy: are mitochondria the key? , 2010, Journal of Alzheimer's disease : JAD.
[36] F. Jessen,et al. Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing , 2010, Experimental Neurology.
[37] Sudha Seshadri,et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.
[38] Yue Wang,et al. ADAM17 Activity and Other Mechanisms of Soluble L-selectin Production during Death Receptor-Induced Leukocyte Apoptosis , 2010, The Journal of Immunology.
[39] M. L. Genova,et al. Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject. , 2010, Antioxidants & redox signaling.
[40] B. Hyman,et al. The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide , 2010, PloS one.
[41] Brent D. Cameron,et al. Inflammation, microglia, and alzheimer's disease , 2010, Neurobiology of Disease.
[42] Bo Li,et al. Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-α-dependent , 2010, Neurobiology of Aging.
[43] H. Hampel,et al. Blood-based biomarkers of microvascular pathology in Alzheimer’s disease , 2010, Experimental Gerontology.
[44] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[45] David J. Begley,et al. Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.
[46] Dominique Drouin,et al. Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression , 2010, Alzheimer's & Dementia.
[47] Martin Ingelsson,et al. The Alzheimer's Disease-Associated Amyloid \(\beta\)-Protein Is an Antimicrobial Peptide , 2010 .
[48] Xiongwei Zhu,et al. Abnormal mitochondrial dynamics and neurodegenerative diseases. , 2010, Biochimica et biophysica acta.
[49] C. Laske,et al. Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients. , 2010, Journal of Alzheimer's disease : JAD.
[50] Muzamil Saleem,et al. Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.
[51] Monique Breteler,et al. Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels , 2009, Annals of the New York Academy of Sciences.
[52] Nick C Fox,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes , 2009, Nature Genetics.
[53] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[54] Steve Horvath,et al. Molecular Systems Biology 5; Article number 291; doi:10.1038/msb.2009.46 Citation: Molecular Systems Biology 5:291 , 2022 .
[55] J. Sayre,et al. Immune blood biomarkers of Alzheimer disease patients , 2009, Journal of Neuroimmunology.
[56] S. Lovestone,et al. Biomarkers for Alzheimer’s disease trials — biomarkers for what? A discussion paper , 2009, The journal of nutrition, health & aging.
[57] Bo Li,et al. Amyloid β Interaction with Receptor for Advanced Glycation End Products Up-Regulates Brain Endothelial CCR5 Expression and Promotes T Cells Crossing the Blood-Brain Barrier1 , 2009, The Journal of Immunology.
[58] D. Wallace,et al. A novel NDUFA1 mutation leads to a progressive mitochondrial complex I-specific neurodegenerative disease. , 2009, Molecular genetics and metabolism.
[59] S. Donato,et al. Multisystem manifestations of mitochondrial disorders , 2009, Journal of Neurology.
[60] T. Suuronen,et al. Inflammation in Alzheimer's disease: Amyloid-β oligomers trigger innate immunity defence via pattern recognition receptors , 2009, Progress in Neurobiology.
[61] S. Teichmann,et al. A HaemAtlas: characterizing gene expression in differentiated human blood cells , 2008, Blood.
[62] J. Ryu,et al. A leaky blood–brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain , 2008, Journal of cellular and molecular medicine.
[63] Angela P. Presson,et al. Integrated Weighted Gene Co-expression Network Analysis with an Application to Chronic Fatigue Syndrome , 2008, BMC Systems Biology.
[64] S. Horvath,et al. Functional organization of the transcriptome in human brain , 2008, Nature Neuroscience.
[65] A. Passaro,et al. Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia , 2008, Journal of the Neurological Sciences.
[66] D. Geschwind,et al. Gene expression study on peripheral blood identifies progranulin mutations , 2008, Annals of neurology.
[67] G. Narkis,et al. Mitochondrial complex III deficiency associated with a homozygous mutation in UQCRQ. , 2008, American journal of human genetics.
[68] T. Kuijpers,et al. Mitochondrial Membrane Potential in Human Neutrophils Is Maintained by Complex III Activity in the Absence of Supercomplex Organisation , 2008, PloS one.
[69] Eric M Reiman,et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. , 2008, Physiological genomics.
[70] David R. Willé,et al. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium‐derived factor: Two novel biomarkers of Alzheimer's disease in human plasma , 2008, Proteomics. Clinical applications.
[71] Winnie S. Liang,et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.
[72] Claudius Mueller,et al. Immunophenotypes in the circulation of patients with mild cognitive impairment. , 2008, Journal of psychiatric research.
[73] Y. Xing,et al. A Transcriptome Database for Astrocytes, Neurons, and Oligodendrocytes: A New Resource for Understanding Brain Development and Function , 2008, The Journal of Neuroscience.
[74] Judith A. Blake,et al. The Mouse Genome Database (MGD): mouse biology and model systems , 2007, Nucleic Acids Res..
[75] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[76] D. Stephan,et al. A survey of genetic human cortical gene expression , 2007, Nature Genetics.
[77] F. Rossi,et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.
[78] C. Cotman,et al. Inflammatory changes parallel the early stages of Alzheimer disease , 2007, Neurobiology of Aging.
[79] R. Tibshirani,et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.
[80] O. Sorgenfrei,et al. The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia , 2007, BMC Genomics.
[81] Ann Saada,et al. Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation , 2007, Journal of Medical Genetics.
[82] W. Aird,et al. G Protein-Coupled Receptor Ca2+-Linked Mitochondrial Reactive Oxygen Species Are Essential for Endothelial/Leukocyte Adherence , 2007, Molecular and Cellular Biology.
[83] Animesh Nandi,et al. Serum biomarkers for Alzheimer's disease: proteomic discovery. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[84] F. Robert,et al. Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense. , 2007, Genes & development.
[85] S Lovestone,et al. Biomarkers for disease modification trials--the innovative medicines initiative and AddNeuroMed. , 2007, The journal of nutrition, health & aging.
[86] F. Sánchez‐Madrid,et al. Expression and Regulation of the Metalloproteinase ADAM-8 during Human Neutrophil Pathophysiological Activation and Its Catalytic Activity on L-Selectin Shedding1 , 2007, The Journal of Immunology.
[87] R. Petersen,et al. Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease , 2007 .
[88] J. Smeitink,et al. Superoxide production is inversely related to complex I activity in inherited complex I deficiency. , 2007, Biochimica et biophysica acta.
[89] Michael T. Heneka,et al. Inflammatory processes in Alzheimer's disease , 2007, Journal of Neuroimmunology.
[90] A. Cassard-Doulcier,et al. Mitochondria contribute to LPS-induced MAPK activation via uncoupling protein UCP2 in macrophages. , 2007, The Biochemical journal.
[91] Allan R. Jones,et al. Genome-wide atlas of gene expression in the adult mouse brain , 2007, Nature.
[92] R. Rodenburg,et al. X‐linked NDUFA1 gene mutations associated with mitochondrial encephalomyopathy , 2007, Annals of neurology.
[93] R. Petersen,et al. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. , 2007, Archives of neurology.
[94] J. Pantel,et al. Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease. , 2007, Journal of neural transmission. Supplementum.
[95] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[96] R. Flavell,et al. T-cells in alzheimer’s disease , 2007, NeuroMolecular Medicine.
[97] P. Reddy,et al. Differential expression of oxidative phosphorylation genes in patients with Alzheimer’s disease , 2007, NeuroMolecular Medicine.
[98] L. Frölich,et al. Impact of aging , 2007, NeuroMolecular Medicine.
[99] Andy M. Yip,et al. Gene network interconnectedness and the generalized topological overlap measure , 2007, BMC Bioinformatics.
[100] Tracy L. Niedzielko,et al. Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment. , 2006, Mitochondrion.
[101] S. Horvath,et al. Conservation and evolution of gene coexpression networks in human and chimpanzee brains , 2006, Proceedings of the National Academy of Sciences.
[102] K. Isobe,et al. Amyloid-β peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway , 2006, Neuroscience Research.
[103] E. Raines,et al. Emerging roles for ectodomain shedding in the regulation of inflammatory responses , 2006, Journal of leukocyte biology.
[104] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[105] E. Tangalos,et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. , 2006, Archives of neurology.
[106] V. Petruzzella,et al. Dysfunctions of Cellular Oxidative Metabolism in Patients with Mutations in the NDUFS1 and NDUFS4 Genes of Complex I* , 2006, Journal of Biological Chemistry.
[107] Xiaohui S. Xie,et al. A Mammalian Organelle Map by Protein Correlation Profiling , 2006, Cell.
[108] D. Kuhn,et al. Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[109] L. Lue,et al. Gene expression changes by amyloid β peptide‐stimulated human postmortem brain microglia identify activation of multiple inflammatory processes , 2006, Journal of leukocyte biology.
[110] J. Julien,et al. Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.
[111] M. Karas,et al. Immunoisolation of two synaptic vesicle pools from synaptosomes: a proteomics analysis , 2005, Journal of neurochemistry.
[112] A. Stalder,et al. Invasion of Hematopoietic Cells into the Brain of Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.
[113] L. Frölich,et al. Enhanced ROS-generation in lymphocytes from Alzheimer's patients. , 2005, Pharmacopsychiatry.
[114] V. Mathura,et al. Genomic regulation after CD40 stimulation in microglia: relevance to Alzheimer's disease. , 2005, Brain research. Molecular brain research.
[115] S. Horvath,et al. Statistical Applications in Genetics and Molecular Biology , 2011 .
[116] S. Ginsberg,et al. Expression profile analysis within the human hippocampus: Comparison of CA1 and CA3 pyramidal neurons , 2005, The Journal of comparative neurology.
[117] Hsueh‐Meei Huang,et al. Mitochondrial function in fibroblasts with aging in culture and/or Alzheimer's disease , 2005, Neurobiology of Aging.
[118] F. González-Scarano,et al. Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression , 2004, Journal of Neuroimmunology.
[119] C. Petito,et al. Gene expression profiles in microdissected neurons from human hippocampal subregions. , 2004, Brain research. Molecular brain research.
[120] J. Kusiak,et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 are involved in both excitotoxin-induced neurodegeneration and regeneration. , 2004, Experimental cell research.
[121] W. Wong,et al. Molecular diversity of astrocytes with implications for neurological disorders. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[122] E. Lein,et al. Defining a Molecular Atlas of the Hippocampus Using DNA Microarrays and High-Throughput In Situ Hybridization , 2004, The Journal of Neuroscience.
[123] L. Gan,et al. Identification of Cathepsin B as a Mediator of Neuronal Death Induced by Aβ-activated Microglial Cells Using a Functional Genomics Approach* , 2004, Journal of Biological Chemistry.
[124] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[125] W. Markesbery,et al. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[126] I. Santana,et al. Cytochrome c oxidase is decreased in Alzheimer’s disease platelets , 2004, Neurobiology of Aging.
[127] P. Bénit,et al. Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome , 2004, Journal of Medical Genetics.
[128] D. Butterfield,et al. The Expression of Several Mitochondrial and Nuclear Genes Encoding the Subunits of Electron Transport Chain Enzyme Complexes, Cytochrome c Oxidase, and NADH Dehydrogenase, in Different Brain Regions in Alzheimer's Disease , 1999, Neurochemical Research.
[129] Anne Eckert,et al. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. , 2003, Biochemical pharmacology.
[130] L. Murri,et al. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease , 2003, Experimental Neurology.
[131] Steffen Jung,et al. Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.
[132] G. Prendergast,et al. Targeted Disruption of the Murine Bin1/Amphiphysin II Gene Does Not Disable Endocytosis but Results in Embryonic Cardiomyopathy with Aberrant Myofibril Formation , 2003, Molecular and Cellular Biology.
[133] P. Rustin,et al. A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis , 2003, Human Genetics.
[134] R. Moots,et al. The Mitochondrial Network of Human Neutrophils: Role in Chemotaxis, Phagocytosis, Respiratory Burst Activation, and Commitment to Apoptosis 1 , 2003, The Journal of Immunology.
[135] B. Walzog,et al. A role for apoptosis in the control of neutrophil homeostasis in the circulation: insights from CD18-deficient mice. , 2003, Blood.
[136] H. Erdjument-Bromage,et al. Conversion of Proepithelin to Epithelins Roles of SLPI and Elastase in Host Defense and Wound Repair , 2002, Cell.
[137] M. Ball,et al. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.
[138] J. Verhoef,et al. Amyloid-β-induced chemokine production in primary human macrophages and astrocytes , 2002, Journal of Neuroimmunology.
[139] Gabriele Siciliano,et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease , 2002, Neurobiology of Aging.
[140] Masanori Kato,et al. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases , 2002, Journal of Neuroimmunology.
[141] M. Frotscher,et al. Targeting gene-modified hematopoietic cells to the central nervous system: Use of green fluorescent protein uncovers microglial engraftment , 2001, Nature Medicine.
[142] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[143] W. Markesbery,et al. Accuracy of clinical criteria for AD in the Honolulu–Asia Aging Study, a population-based study , 2001, Neurology.
[144] C. Haass,et al. Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation , 2001, Journal of neuroscience research.
[145] C. Luckhaus,et al. Alzheimer's Disease-like Alterations in Peripheral Cells from Presenilin-1 Transgenic Mice , 2001, Neurobiology of Disease.
[146] B. Zlokovic,et al. beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. , 2000, American journal of physiology. Cell physiology.
[147] C. Bingle,et al. Inflammatory neutrophils retain susceptibility to apoptosis mediated via the Fas death receptor , 2000, Journal of leukocyte biology.
[148] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[149] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[150] L. P. Van den Heuvel,et al. Isolated complex I deficiency in children: Clinical, biochemical and genetic aspects , 2000, Human mutation.
[151] R. Kalaria. The Blood‐Brain Barrier and Cerebrovascular Pathology in Alzheimer's Disease , 1999, Annals of the New York Academy of Sciences.
[152] G. Romano,et al. Biological activities and signaling pathways of the granulin/epithelin precursor. , 1999, Cancer research.
[153] H. Wiśniewski,et al. Plasma amyloid β‐peptide 1–42 and incipient Alzheimer's disease , 1999 .
[154] R. Cacabelos,et al. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals , 1999, Journal of Neuroimmunology.
[155] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[156] D. Neary,et al. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia , 1999, Journal of neurology, neurosurgery, and psychiatry.
[157] S A Small,et al. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease. , 1999, Annals of neurology.
[158] W. Markesbery,et al. Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.
[159] M. Weinand,et al. Amyloid-β Induces Chemokine Secretion and Monocyte Migration across a Human Blood-Brain Barrier Model , 1998, Molecular medicine.
[160] J. Rhodin,et al. In vivo vascular damage, leukocyte activation and inflammatory response induced by beta-amyloid. , 1997, Journal of submicroscopic cytology and pathology.
[161] John Hardy,et al. Amyloid, the presenilins and Alzheimer's disease , 1997, Trends in Neurosciences.
[162] M. Sano,et al. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.
[163] R. Veerhuis,et al. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease , 1996, Neurobiology of Aging.
[164] N. Inestrosa,et al. Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood , 1995 .
[165] N. Inestrosa,et al. Platelets are the primary source of amyloid beta-peptide in human blood. , 1995, Biochemical and biophysical research communications.
[166] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[167] M. Mega,et al. The Neuropsychiatric Inventory , 1994, Neurology.
[168] C. Filley,et al. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease , 1994, Neurology.
[169] L. Lapham,et al. Clinicopathologic Correlates in Alzheimer Disease: Assessment of Clinical and Pathologic Diagnostic Criteria , 1993, Alzheimer disease and associated disorders.
[170] N Butters,et al. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. , 1991, Archives of neurology.
[171] S. Styren,et al. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.
[172] P. Mcgeer,et al. Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue , 1988, Neuroscience Letters.
[173] B. Reisberg,et al. Global Deterioration Scale (GDS). , 1988, Psychopharmacology bulletin.
[174] K. Davis,et al. A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.
[175] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.
[176] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[177] J. H. Ward. Hierarchical Grouping to Optimize an Objective Function , 1963 .